Al's Comment:

 I did not really expect it to do well by itself. I feel that it may be part of a combination approach with other immune therapies. We are funding such a combination trial now!


Posted on: 04/05/2017

Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!